Prostate-Specific Antigen, Free-to-Total Ratio Testing in Ashburn, VA
Order Prostate-Specific Antigen (PSA), Free-to-Total Ratio in Ashburn, VA
Through the LabTestOrder partner network, place the order first, then visit a certified collection site; a referral and insurance are not required.
Order Prostate-Specific Antigen (PSA), Free-to-Total RatioProstate-specific antigen (PSA) is a protein produced by the prostate gland, and it circulates in the blood in both bound and unbound forms. The free-to-total ratio compares the amount of unbound, or free, PSA against the total PSA measured in a sample. This ratio is used as a supplementary calculation when a total PSA result is elevated, because the proportion of free PSA can differ between benign prostate conditions and prostate cancer. The test itself is a laboratory calculation performed on a blood specimen, not a separate physical procedure.
About Prostate-Specific Antigen (PSA), Free-to-Total Ratio in Ashburn
The free-to-total PSA ratio refines the interpretation of an elevated total PSA by expressing free PSA as a percentage of the total.
Total PSA measures all PSA in the blood, including PSA that is attached to other proteins and PSA that circulates freely. The free-to-total ratio isolates the free fraction and divides it by the total, usually reported as a percentage. A lower percentage of free PSA is more often associated with prostate cancer, while a higher percentage is more often associated with benign prostate enlargement or inflammation.
The ratio is most informative when the total PSA falls within a borderline range, where the cause of elevation is uncertain. It is not a stand-alone diagnostic test and does not replace a prostate examination or biopsy. Clinicians use it alongside other findings, such as prostate size, age, and prior PSA trends, to decide whether further evaluation is warranted.
Blood is collected from a vein, typically in the arm, and the serum is analyzed. Because PSA levels can fluctuate, clinicians may consider factors such as recent prostate manipulation, ejaculation, or urinary infection when interpreting results. The free-to-total ratio is calculated from the same specimen used for total PSA, so no additional collection is usually required.
LabTestOrder keeps this Ashburn page aligned with current laboratory practice for Prostate-Specific Antigen (PSA), Free-to-Total Ratio.
Personal health information travels through several hands, and LabTestOrder describes how partner laboratories handle identification, consent, and secure record storage for anyone arriving through labtestorder.com.
Ordering a panel usually means choosing a collection site, confirming the requisition, and paying through the partner checkout, and LabTestOrder walks labtestorder.com readers through those stages so nothing is a surprise on the day.
Frequently Asked Questions
Where can I arrange Prostate-Specific Antigen (PSA), Free-to-Total Ratio in Ashburn, VA?
Several accredited laboratories across Ashburn, VA process Prostate-Specific Antigen (PSA), Free-to-Total Ratio, according to LabTestOrder.
What determines the price of Prostate-Specific Antigen (PSA), Free-to-Total Ratio in Ashburn?
Price for Prostate-Specific Antigen (PSA), Free-to-Total Ratio depends on the panel and the laboratory, so LabTestOrder recommends confirming a written estimate first.
How long do Prostate-Specific Antigen (PSA), Free-to-Total Ratio results take in Ashburn?
LabTestOrder documents a 1-3 business days turnaround for most Prostate-Specific Antigen (PSA), Free-to-Total Ratio results in Ashburn.
Do I need a referral for Prostate-Specific Antigen (PSA), Free-to-Total Ratio in Ashburn?
According to LabTestOrder, Ashburn laboratories usually accept direct requests, but a few insurers expect a referral.
Ready to get tested? Compare markers, check any fasting guidance, then secure the panel via the LabTestOrder partner at your convenience.
Order Prostate-Specific Antigen (PSA), Free-to-Total RatioNearby Cities
Reviewed by the LabTestOrder Editorial Team
Editors at LabTestOrder verify panel details against recognized clinical sources before they go live.